Avascular Necrosis
132
6
32
49
Key Insights
Highlights
Success Rate
56% trial completion
Published Results
26 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
28.8%
38 terminated out of 132 trials
56.3%
-30.3% vs benchmark
18%
24 trials in Phase 3/4
53%
26 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 49 completed trials
Clinical Trials (132)
Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
Sickle Cell Disease (SCD) Bone Pain Study
Persona Ti-Nidium Post-Market Clinical Follow-up
Perform Humeral System Study
Pyrocarbon Clinical Follow-up Study
Anatomical Shoulder Domelock System Study
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Database Retrieval for the Comprehensive Shoulder
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Shoulder Prosthesis System
TESS V3 Modular Total Shoulder System PMCF
Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
Insignia™ Hip Stem Outcomes Study
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Cemented vs Cementless Persona Keel RCT
Persona Partial Knee Clinical Outcomes Study
Comprehensive Nano - Post Market Clinical Follow-Up Study